17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol has been researched along with drospirenone in 1 studies
| Studies (17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol) | Trials (17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol) | Recent Studies (post-2010) (17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol) | Studies (drospirenone) | Trials (drospirenone) | Recent Studies (post-2010) (drospirenone) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 530 | 177 | 262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirk, RA; Winneker, RC; Zhang, Z | 1 |
1 other study(ies) available for 17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol and drospirenone
| Article | Year |
|---|---|
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Topics: Androstenes; Animals; Antithrombins; Blood Coagulation; Cholesterol; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Models, Animal; Norethindrone; Norethindrone Acetate; Norethynodrel; Ovariectomy; Progestins; Promegestone; Rats; Rats, Sprague-Dawley | 2005 |